Credit reporting giant Equifax (NYSE: EFX) will be reporting earnings tomorrow morning. Here’s what investors should know.

Equifax missed analysts’ revenue expectations by 1.4% last quarter, reporting revenues of $1.42 billion, up 7% year on year. It was a softer quarter for the company, with revenue guidance for next quarter slightly missing analysts’ expectations.

Is Equifax a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Equifax’s revenue to grow 2% year on year to $1.42 billion, slowing from the 6.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.40 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Equifax has missed Wall Street’s revenue estimates five times over the last two years.

Looking at Equifax’s peers in the professional services segment, some have already reported their Q1 results, giving us a hint as to what we can expect. ManpowerGroup’s revenues decreased 7.1% year on year, beating analysts’ expectations by 2.9%, and Concentrix reported a revenue decline of 1.3%, in line with consensus estimates. Concentrix traded up 42.3% following the results.

Read our full analysis of ManpowerGroup’s results here and Concentrix’s results here.

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.